*MACE defined in ODYSSEY OUTCOMES clinical trial as composite of coronary heart disease death, non-fatal myocardial infarction, fatal and non-fatal ischaemic stroke, or unstable angina requiring hospitalisation1
CI, confidence interval; CV, cardiovascular; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; MACE, Major adverse cardiovascular event; MI, myocardial infarction
References
SAGB.ALI.19.02.0295(1) | July 2019